Immunotherapy & Vaccines
JPT Peptide Technologies possesses a variety of unique peptide based technologies allowing for systematic and proteome spanning B- and T-cell biomarker discovery, immune monitoring and clinical development of immunotherapy and vaccines. Our tools and know-how are currently and have been successfully used in various projects leading to novel approaches in indications such as cancer, infection, autoimmune disease and allergy.
In contrast to other approaches on the market, our technologies enable the monitoring of individual epitope patterns as well as epitope spreading and address natural sequence diversity and post-translational modifications.
Contact us for further information and discussion!